Depression Clinical Trials in Miami, FL

Depression Clinical Trials in Miami, FL

View the best 10 depression medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Depression clinical trial.

Trials in Miami, Florida

Here are the top 10 medical studies for depression in Miami, Florida

Image of Advanced Research Center /ID# 227073 in Anaheim, United States.

Placebo +1 More

Pharmacotherapy

Recruiting1 awardPhase 3
This trial is testing the safety and effectiveness of Cariprazine for treating depressive episodes in children and teenagers with bipolar I disorder. The goal is to find out if Cariprazine can help young people with this condition. Cariprazine is an atypical antipsychotic recently approved for the treatment of depressive episodes in adults with bipolar I disorder.
Image of Vilma Gabbay, MD, MS in Bronx, United States.

MRI study

Recruiting1 award
This trial is studying how using cannabis and having depression together affect young people living with HIV. Researchers believe that these conditions combined might make it harder for them to feel pleasure and could increase their sensitivity to pain. The goal is to see if these effects lead to worse health outcomes over time.
Image of Chicago Research Center in Chicago, United States.

Aticaprant

Recruiting1 awardPhase 3
This trial aims to see if aticaprant is effective in preventing the return of depression symptoms when added to antidepressant therapy in individuals with major depressive disorder who have already responded well to aticaprant treatment
Image of For additional information regarding sites, contact 844-687-8522 in Austin, United States.

Placebo +1 More

Recruiting0 awardsPhase 2
This trial is testing a drug to treat Major Depressive Disorder in adults who haven't responded to other treatments. It will last 6 weeks and have 336 subjects in the United States.
Image of OMNI Medical Services in Boca Raton, United States.

Medical Cannabis

Cannabinoid

Recruiting1 awardPhase 2
This trial will investigate if medical cannabis can effectively reduce pain and improve quality of life for patients with chronic conditions. The study will gather data through an online questionnaire about patients' use of cannabis and its effects. Medical cannabis interacts with the body's natural system to help manage pain and other symptoms. Medical cannabis has been increasingly studied and used as an alternative treatment for managing chronic pain, with numerous studies supporting its potential benefits.
Image of Child and Adolescent Mood and Anxiety Treatment Program in Coral Gables, United States.

The Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Children +1 More

Behavioral Intervention

Recruiting1 award7 criteria
This trial tests a cognitive-behavioral therapy to treat emotional disorders in youth & their parents, evaluating results with standardized measures.
Image of Neumora Investigator Site in Lauderhill, United States.

NMRA-335140

Recruiting0 awardsPhase 2
This trial is testing a new medication called NMRA-335140 to see if it can help adults with Bipolar II disorder who are experiencing major depression. The medication aims to improve mood and reduce feelings of depression.
Image of Clinical Site in Anaheim, United States.

Lumateperone

Behavioural Intervention

Recruiting1 awardPhase 3
"This trial is studying the effectiveness of a new treatment for children with bipolar disorder who are also experiencing major depressive episodes. The study is being conducted at multiple locations and will involve random assignment of participants to receive
Image of Clinical Research Site in Encino, United States.

Solriamfetol

Behavioural Intervention

Recruiting1 awardPhase 3
This trial is testing solriamfetol, a medication that may help improve symptoms of depression. It targets adults with major depressive disorder (MDD) who do not have psychotic features. Solriamfetol works by affecting brain chemicals involved in mood regulation, potentially helping to improve mood and reduce depression symptoms.
Image of Reverie Mind, LLC in Chandler, United States.

BHV-7000

Behavioural Intervention

Recruiting1 awardPhase 2
This trial is testing a new medication called BHV-7000 to see if it is safe and well-tolerated over several months in people with Major Depressive Disorder. The goal is to help those who suffer from severe depression by potentially offering a new treatment option.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.